𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Imatinib mesylate in chordoma

✍ Scribed by Paolo G. Casali; Antonella Messina; Silvia Stacchiotti; Elena Tamborini; Flavio Crippa; Alessandro Gronchi; Rosaria Orlandi; Carla Ripamonti; Carlo Spreafico; Raffaello Bertieri; Rossella Bertulli; Maurizio Colecchia; Elena Fumagalli; Angela Greco; Federica Grosso; Patrizia Olmi; Marco A. Pierotti; Silvana Pilotti

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
716 KB
Volume
101
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Imatinib mesylate causes hypopigmentatio
Imatinib mesylate causes hypopigmentation in the skin
✍ Anne S. Tsao; Hagop Kantarjian; Jorge Cortes; Susan O'Brien; Moshe Talpaz πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 218 KB

## Background: Imatinib mesylate is a tyrosine kinase inhibitor that targets the bcr-abl protein in cml, c-kit (kit) and platelet-derived growth factor receptors. in clinical trials with imatinib mesylate, common side effects of nausea, emesis, diarrhea, periorbital edema, fluid retention, and myel

Imatinib mesylate causes hypopigmentatio
Imatinib mesylate causes hypopigmentation in the skin
✍ Kin Wah Leong; Thoong Chow Lee; Ai Sim Goh πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 69 KB

## Cancer-Related Fatigue: Evolving Concepts in Evaluation and Treatment I n their otherwise excellent review of cancer-related fatigue, Stasi et al. 1 failed to discuss opioid-induced androgen deficiency (OPIAD), an extremely common and easily identified cause of fatigue in men with malignant dis